RBM17 and colorectal cancer: demonstrated that the tRF‐5a fragment modulates the radiation resistance of colorectal cancer cells by targeting MKNK1 [8], whereas tiRNA‐Gly enhances the proliferation and migration of thyroid papillary carcinoma by interacting with RBM17 and causing alternative splicing [38].